Cross Ctry Healthcare Inc Stock Price, News & Analysis

Cross Country Healthcare (NASDAQ: CCRN) has been recognized with several ClearlyRated's Best of Staffing® awards, highlighting its exceptional customer service across brands. Notable awards include Best of Staffing Talent, Best of Staffing Client, and the Best of Staffing Diamond award. These accolades underscore the organization's commitment to delivering high-quality talent management solutions, especially during challenging times. CEO Kevin C. Clark emphasized the importance of trust and relationships with clients, which is reflected in the satisfaction ratings.

Cross Country Healthcare (Nasdaq: CCRN) is set to attend two upcoming virtual conferences. On March 9-10, 2021, CEO Kevin C. Clark and CFO William J. Burns will hold one-on-one investor meetings at the Truist Securities 2021 Technology, Internet & Services Virtual Conference. Following this, on March 16-17, 2021, CFO Burns and Group President Buffy S. White will participate in similar meetings at the Oppenheimer 31st Annual Virtual Healthcare Conference. No formal presentations will be made at either event.

Cross Country Healthcare, Inc. (Nasdaq: CCRN) has been recognized on Staffing Industry Analysts’ (SIA) 2020 list of Largest Staffing Firms in the U.S., achieving the 21st position. This annual list includes 175 companies with a minimum of $100 million in staffing revenue in 2019. The collective revenue of these firms totaled $96.7 billion, accounting for 63.5% of the U.S. staffing market. CEO Kevin C. Clark emphasized that this recognition reflects the dedication of their employees.

Cross Country Healthcare (Nasdaq: CCRN) announced that group president Buffy Stultz White has been recognized on Staffing Industry Analysts’ 2020 Global Power 150 Women in Staffing list for the second consecutive year. White leads workforce solutions and sales across the organization, contributing to operational efficiencies and improved production. The Global Power 150 list honors women in leadership who impact the $498 billion staffing industry. CEO Kevin C. Clark praised White's extensive experience and emphasized the company's commitment to diversity among its predominantly female workforce.

Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold a conference call on February 24, 2021, at 5:00 p.m. ET to discuss its Q4 and full-year 2020 financial results. The earnings press release will be distributed after market close on the same day. The call will be accessible via the company’s website or by phone. Cross Country Healthcare is a leader in total talent management within the healthcare sector, and it has a commitment to high service levels, diversity, and social responsibility. Audio replays will be available from February 24 through March 11, 2021.

Cross Country Healthcare (Nasdaq: CCRN) has appointed John A. Martins as Group President of Nurse and Allied services, effective immediately. Martins brings over 15 years of experience in healthcare staffing, with expertise in travel nurse and digital innovation. He previously led Onward Healthcare and served as SVP of Operations Strategy at Aya Healthcare. CEO Kevin C. Clark emphasized Martins' track record in driving growth and profitability, illustrating confidence in the company's future market leadership.

Cross Country Healthcare (Nasdaq: CCRN) has launched the Cross Country Healthcare Scholarship Fund in partnership with Florida Atlantic University’s Christine E. Lynn College of Nursing. This initiative aims to provide annual scholarships and support educational opportunities for nursing students over a minimum of four years. CEO Kevin Clark emphasized the importance of this fund in enhancing the nursing workforce and addressing community healthcare needs. FAU's College of Nursing, noted for its high-quality programs and research, expressed gratitude for the support, which aims to alleviate financial barriers for aspiring nurses.

Cross Country Healthcare (CCRN) reported third quarter 2020 financial results with revenue of $194 million, down 7% year-over-year. Gross profit margin improved to 24.7%, while net loss attributable to common shareholders was $1.3 million, significantly reduced from previous quarters. Adjusted EBITDA reached $8.6 million, reflecting improved operational efficiency. However, the company anticipates fourth quarter revenue to decline 9% to 14% year-over-year, with wider guidance ranges due to ongoing impacts from COVID-19.